Keywords: wyeth-ayerst, gains, fda, ok, rapamune, tablet, been
Wyeth-Ayerst gains FDA OK for Rapamune tablet
Article | 31 August 2000
Wyeth-Ayerst has been granted clearance from the US Food and DrugAdministration to market a tablet formulation of its transplant immunosuppressant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
